doi: 10.1093/cid/ciaa1486.
Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant
Affiliations
- PMID: 33159210
- DOI: 10.1093/cid/ciaa1486
Item in Clipboard
Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant
Clin Infect Dis.
.
Abstract
Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin-producing Escherichia coli (STEC). No patients died of FMT-transmitted STEC. Improved screening can likely avoid future transmission.
Keywords: Clostridioides difficile; FMT; STEC; Shiga toxin-producing E. coli; fecal microbiota transplantation.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Fecal Microbiota Transplantation: Tales of Caution.Clin Infect Dis. 2021 Jun 1;72(11):e881-e882. doi: 10.1093/cid/ciaa1492. Clin Infect Dis. 2021. PMID: 32991697 No abstract available.
Similar articles
-
Fecal Microbiota Transplantation: The Evolving Risk Landscape.Am J Gastroenterol. 2021 Apr;116(4):647-656. doi: 10.14309/ajg.0000000000001075. Am J Gastroenterol. 2021. PMID: 33982930 Review.
-
High carriage rate of extended-spectrum β-lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation.Eur J Clin Microbiol Infect Dis. 2023 Sep;42(9):1103-1113. doi: 10.1007/s10096-023-04644-3. Epub 2023 Jul 20. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37474764
-
Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.Gastroenterology. 2021 Oct;161(4):1218-1228.e5. doi: 10.1053/j.gastro.2021.06.009. Epub 2021 Jun 11. Gastroenterology. 2021. PMID: 34126062
-
Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.JCI Insight. 2019 Oct 3;4(19):e130848. doi: 10.1172/jci.insight.130848. JCI Insight. 2019. PMID: 31578306 Free PMC article.
-
Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.J Clin Microbiol. 2022 Feb 16;60(2):e0016121. doi: 10.1128/JCM.00161-21. Epub 2021 Jun 16. J Clin Microbiol. 2022. PMID: 34133889 Free PMC article. Review.
Cited by
-
Clostridioides difficile Infection: Diagnosis and Treatment Challenges.Pathogens. 2024 Jan 27;13(2):118. doi: 10.3390/pathogens13020118. Pathogens. 2024. PMID: 38392856 Free PMC article. Review.
-
Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases.Signal Transduct Target Ther. 2024 Feb 16;9(1):37. doi: 10.1038/s41392-024-01743-1. Signal Transduct Target Ther. 2024. PMID: 38360862 Free PMC article. Review.
-
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy.EBioMedicine. 2024 Feb;100:104967. doi: 10.1016/j.ebiom.2024.104967. Epub 2024 Jan 18. EBioMedicine. 2024. PMID: 38241975 Free PMC article. Review.
-
Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches.Trop Med Infect Dis. 2023 Nov 23;8(12):506. doi: 10.3390/tropicalmed8120506. Trop Med Infect Dis. 2023. PMID: 38133438 Free PMC article. Review.
-
Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers.Poult Sci. 2024 Feb;103(2):103316. doi: 10.1016/j.psj.2023.103316. Epub 2023 Nov 27. Poult Sci. 2024. PMID: 38128454 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
